Book contents
- Optimizing the Management of Fertility in Women over 40
- Optimizing the Management of Fertility in Women over 40
- Copyright page
- Dedication
- Contents
- Contributors
- Introduction
- Section 1 Demographic Trends
- Section 2 Biological Basis of Female Reproductive Aging: What Happens to the Ovaries and the Uterus as they Age?
- Section 3 Lifestyle, Environment, and Optimizing Reproduction in the 40s
- Section 4 Rethinking and Redefining “Family Planning” for the Twenty-First Century
- Section 5 Optimal Deployment of ART beyond 40
- Section 6 Obstetric Management beyond 40
- Section 7 Children of Older Parents
- Section 8 What Are Realistic Alternatives to Conceiving with Autologous Eggs?
- Section 9 New Technologies
- Section 10 Ethics
- Index
- References
Section 9 - New Technologies
Published online by Cambridge University Press: 15 September 2022
Book contents
- Optimizing the Management of Fertility in Women over 40
- Optimizing the Management of Fertility in Women over 40
- Copyright page
- Dedication
- Contents
- Contributors
- Introduction
- Section 1 Demographic Trends
- Section 2 Biological Basis of Female Reproductive Aging: What Happens to the Ovaries and the Uterus as they Age?
- Section 3 Lifestyle, Environment, and Optimizing Reproduction in the 40s
- Section 4 Rethinking and Redefining “Family Planning” for the Twenty-First Century
- Section 5 Optimal Deployment of ART beyond 40
- Section 6 Obstetric Management beyond 40
- Section 7 Children of Older Parents
- Section 8 What Are Realistic Alternatives to Conceiving with Autologous Eggs?
- Section 9 New Technologies
- Section 10 Ethics
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Optimizing the Management of Fertility in Women over 40 , pp. 163 - 172Publisher: Cambridge University PressPrint publication year: 2022
References
Faddy, MJ, Gosden, RG, Gougeon, A, Richardson, SJ, Nelson, JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Human Reproduction. 1992;7(10):1342–6.CrossRefGoogle ScholarPubMed
Santoro, N. The menopause transition: an update. Human Reproduction Update. 2002;8(2):155–60.Google Scholar
Nikolaou, D. Early ovarian ageing: a hypothesis: Detection and clinical relevance. Human Reproduction. 2003;18(6):1137–9.Google Scholar
Office of National Statistics. Home – Office for National Statistics [Internet]. Ons.gov.uk. 2020. Available from: www.ons.gov.uk/Google Scholar
Ní Bhrolcháin, M, Beaujouan, É. Fertility postponement is largely due to rising educational enrolment. Population Studies. 2012;66(3):311–27.Google Scholar
Welcome to the HFEA | Human Fertilisation and Embryology Authority [Internet]. hfea.gov.uk. [cited 2021 Jun 29]. Available from: http://hfea.gov.ukGoogle Scholar
Gleicher, N, Kushnir, VA, Albertini, DF, Barad, DH. Improvements in IVF in women of advanced age. The Journal of Endocrinology. 2016;230(1):F1-6.Google Scholar
Reznichenko, A, Huyser, C, Pepper, M. Mitochondrial transfer: Implications for assisted reproductive technologies. Applied & Translational Genomics. 2016;11:40–7.Google Scholar
Sfakianoudis, K, Rapani, A, Grigoriadis, S, Retsina, D, Maziotis, E, Tsioulou, P, et al. Novel approaches in addressing ovarian insufficiency in 2019: are we there yet? Cell Transplantation. 2020;29:096368972092615.CrossRefGoogle ScholarPubMed
Cohen, J. Ooplasmic transfer in mature human oocytes. Molecular Human Reproduction. 1998;4(3):269–80.Google Scholar
Fakih, MH. The AUGMENTSM treatment: physician reported outcomes of the initial global patient experience. Journal of Fertilization: In Vitro – IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology. 2015;03(03).Google Scholar
Tachibana, M, Kuno, T, Yaegashi, N. Mitochondrial replacement therapy and assisted reproductive technology: A paradigm shift toward treatment of genetic diseases in gametes or in early embryos. Reproductive Medicine and Biology. 2018;17(4):421–33.Google Scholar
Reznichenko, A, Huyser, C, Pepper, MS. Mitochondrial transfer: Ethical, legal and social implications in assisted reproduction. South African Journal of Bioethics and Law. 2015;8(2):32.Google Scholar
Ernst, EH, Grøndahl, ML, Grund, S, Hardy, K, Heuck, A, Sunde, L, et al. Dormancy and activation of human oocytes from primordial and primary follicles: molecular clues to oocyte regulation. Human Reproduction. 2017;32(8):1684–700.Google Scholar
Hsueh, AJW, Kawamura, K. Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertility and Sterility. 2020;114(3):458–64.Google Scholar
Tilly, JL, Telfer, EE. Purification of germline stem cells from adult mammalian ovaries: a step closer towards control of the female biological clock? Molecular Human Reproduction. 2009;15(7):393–8.CrossRefGoogle ScholarPubMed
Sfakianoudis, K, Simopoulou, M, Grigoriadis, S, Pantou, A, Tsioulou, P, Maziotis, E, et al. Reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women. Journal of Clinical Medicine. 2020;9(6).CrossRefGoogle ScholarPubMed
Anitua, E, Prado, R, Padilla, S, Orive, G. Platelet-rich plasma therapy: another appealing technology for regenerative medicine? Regenerative Medicine. 2016;11(4):355–7.Google Scholar
Panda, SR, Sachan, S, Hota, S. A systematic review evaluating the efficacy of intra-ovarian infusion of autologous platelet-rich plasma in patients with poor ovarian reserve or ovarian insufficiency. Cureus. 2020;12(12):e12037.Google ScholarPubMed
Fazeli, Z, Abedindo, A, Omrani, MD, Ghaderian, SMH. Mesenchymal stem cells (MSCs) therapy for recovery of fertility: a systematic review. Stem Cell Reviews and Reports. 2017;14(1):1–12.CrossRefGoogle Scholar
Thomson, JA. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.CrossRefGoogle ScholarPubMed
Kimble, J, Page, DC. The mysteries of sexual identity: the germ cell’s perspective. science. 2007;316(5823):400–1.Google Scholar
Nagy, ZP, Chang, C-C. Current advances in artificial gametes. Reproductive BioMedicine Online. 2005;11(3):332–9.Google Scholar
Takahashi, K, Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.Google Scholar
Hayashi, K, Ogushi, S, Kurimoto, K, Shimamoto, S, Ohta, H, Saitou, M. Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice. Science. 2012 Oct 4;338(6109):971–5.CrossRefGoogle ScholarPubMed
Prigione, A, Lichtner, B, Kuhl, H, Struys, EA, Wamelink, M, Lehrach, H, et al. Human iPSCs harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining hESC-like metabolic reprogramming. Stem Cells. 2011;29(9):1338–1248.Google Scholar
Hockemeyer, D, Jaenisch, R. Induced pluripotent stem cells meet genome editing. Cell Stem Cell. 2016;18(5):573–86.CrossRefGoogle ScholarPubMed
De Masi, C, Spitalieri, P, Murdocca, M, Novelli, G, Sangiuolo, F. Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery. Human Genomics. 2020 Jun 26;14(1).Google Scholar
Cho, E, Kim, YY, Noh, K, Ku, S-Y. A new possibility in fertility preservation: The artificial ovary. Journal of Tissue Engineering and Regenerative Medicine. 2019;13(8):1294–315.Google Scholar